Neospora caninum in Dogs and Bovine Abortion: Immunohistochemistry and Clinical Management
Etiology and Taxonomy
Neospora caninum is an obligate intracellular apicomplexan protozoan parasite belonging to the family Sarcocystidae. It was first recognized as a distinct pathogen in dogs in 1984 and subsequently identified as a major cause of bovine abortion worldwide. The parasite is morphologically similar to Toxoplasma gondii, but it is serologically and genetically distinct. Definitive hosts are canids; dogs (Canis familiaris) and to a lesser extent other canids such as dingoes and gray wolves shed the environmentally resistant oocysts into the environment. Cattle and numerous other intermediate hosts including sheep, goats, horses, and water buffaloes acquire infection through ingestion of sporulated oocysts. Transplacental transmission from dam to fetus is a highly efficient route in both definitive and intermediate hosts.
Lifecycle and Transmission
The life cycle of Neospora caninum is heteroxenous, requiring a canid definitive host and an intermediate host. Dogs excrete unsporulated oocysts in feces. Oocyst sporulation occurs within 24 to 72 hours under optimal environmental conditions of warmth and oxygen. Sporulated oocysts contain two sporocysts, each with four sporozoites. Intermediate hosts become infected by ingesting sporulated oocysts contaminating feed, water, or pasture.
Following ingestion, sporozoites penetrate the intestinal epithelium and disseminate hematogenously throughout the host. Tachyzoites replicate rapidly within a variety of nucleated cells, causing cellular lysis and tissue necrosis. Immune pressure or chemotherapeutic intervention induces conversion to bradyzoites that form tissue cysts in the central nervous system and skeletal muscle. Tachyzoite to bradyzoite interconversion is central to pathogenesis in both dogs and cattle. Dogs become infected by ingesting either oocysts from the environment or, more importantly, by consuming intermediate host tissues containing bradyzoite cysts. This carnivorous route of transmission perpetuates the cycle between livestock and canids.
Epidemiology
Seroprevalence in Dogs
Neospora caninum infection in dogs is globally distributed. Seroprevalence varies widely based on geographic region, dog population, and diagnostic test used. In a study of shelter dogs in Hanoi, Vietnam, seroprevalence was reported using commercial indirect ELISA and immunoblotting [1]. Surveys in Brazil demonstrated high seropositivity in dogs from the Pantanal region and within indigenous communities [2, 3]. In Iraq, molecular detection of Neospora caninum in dogs from Sulaymaniyah province confirmed tissue stage presence via PCR targeting the Nc5 gene [4]. Studies in Jordan and Bangladesh also underscore the ubiquity of the parasite in stray and working dog populations [5, 6]. In Argentina, a 20 year surveillance of dogs with neuromuscular disorders found stable seroprevalence rates, suggesting an endemic cycle [7].
Bovine Neosporosis
Neospora caninum is a leading infectious cause of bovine abortion in dairy herds globally. Herd level seroprevalence based on bulk tank milk ELISA has been documented across Turkey, Chile, Colombia, and Kyrgyzstan, with rates ranging from 20 to over 80 percent [8, 9, 10, 11]. Risk factors for seropositivity include presence of dogs on the farm, lack of biosecurity, and feeding of raw bovine tissues to canids. Water buffaloes also serve as intermediate hosts, as demonstrated by serosurveys in Egypt and Greece [12, 13]. First reports from Bangladesh confirmed Neospora caninum DNA in tissues of aborted bovine, ovine, and caprine fetuses, expanding the known geographic range of endemic neosporosis [6].
Clinical Signs in Dogs
Clinical disease in dogs is predominantly associated with neuromuscular signs, particularly in young animals (congenital neosporosis) and in immunocompromised adults. The hallmark is ascending paralysis of the pelvic limbs, progressing to hindlimb hyperextension and muscle atrophy. Involvement of the cervical spinal cord and brainstem can produce tetraplegia, dysphagia, and cranial nerve deficits. Myositis and myocarditis are also observed. A comprehensive retrospective of 21 adult dogs with neosporosis from 2010 to 2023 showed that clinical presentation in older dogs can mimic other progressive neuromuscular diseases, including immune mediated polymyositis or meningoencephalomyelitis [14]. Another case series described a 3 month old Cane Corso puppy with disseminated Neospora caninum encephalomyelitis and myositis confirmed immunohistochemically [15].
Importantly, subclinical infection is also common. Many seropositive dogs never develop overt disease. Reactivation of latent infection can occur following iatrogenic immunosuppression, as reported in a Doberman treated for immune mediated thrombocytopenia [16]. Fatal disseminated neosporosis has also been documented in seronegative dogs following corticosteroid therapy, a scenario in which immunohistochemistry was essential for ante-mortem diagnosis [17].
Pathology and Immunohistochemistry
Histopathological lesions in neosporosis are consistent with a multifocal necrotizing and non-suppurative inflammation. In dogs, the principal lesions are in the central nervous system: non-suppurative encephalomyelitis characterized by perivascular cuffs of mononuclear cells, glial nodules, and large areas of malacia. Masticatory muscle myositis is a classic feature; magnetic resonance imaging has been used to delineate masticatory muscle changes in dogs with neosporosis compared to meningoencephalitis of unknown origin [18]. In aborted bovine fetuses, the hallmark lesion is multifocal necrotizing encephalitis with gliosis and mineralization. The placenta may exhibit necrotizing cotyledonary lesions with infiltration of lymphocytes and macrophages.
Immunohistochemistry is the gold standard technique for definitive confirmation of Neospora caninum tissue presence. Formalin fixed, paraffin embedded tissues are subjected to enzymatic antigen retrieval and incubation with polyclonal or monoclonal antibodies directed against N. caninum antigens (typically Nc5 or surface antigens). Positive IHC shows intense cytoplasmic staining of tachyzoites and bradyzoite cyst walls. For aborted bovine fetuses, IHC targeting brain tissue is the reference method. In dogs, IHC may be performed on brain, spinal cord, skeletal muscle, or myocardial biopsies. The technique is highly specific and differentiates N. caninum from T. gondii and Hammondia species. A notable differential in dogs is Hammondia heydorni, which has been identified in association with neutrophilic cholangitis and pancreatic duct infection [19, 20]. True biliary tropism is rare for Neospora caninum, making IHC discrimination between these closely related protozoa critical.
Diagnostics: Serology, PCR, and Immunohistochemistry
Serological Testing
Serological diagnosis relies on detection of anti-Neospora caninum IgG and IgM antibodies. Commercial ELISA kits are widely used for both dogs and cattle. Indirect fluorescent antibody tests are also standard. In dogs, seropositivity alone does not confirm active disease; many healthy dogs are seropositive. Seronegative disseminated neosporosis, however, does occur, emphasizing the need for tissue based diagnostics [17]. In cattle, bulk milk ELISA provides a convenient method for herd level surveillance [8]. In one study, a commercially available ELISA detected antibodies in water buffaloes using milk samples, revealing high seroprevalence in that species as well [13].
Polymerase Chain Reaction
Molecular detection using PCR is highly sensitive for Neospora caninum DNA in tissue, cerebrospinal fluid, amniotic fluid, and fetal brain. The Nc5 gene is the standard target for species specific PCR. Quantitative real time PCR (TaqMan assays) have been optimized to determine parasite load. Additionally, CRISPR-Cas9 based knock out studies have employed TaqMan quantitative PCR to confirm integration of selectable markers [21]. For epidemiological surveys, PCR is often combined with serology. For instance, first molecular identification from Iraqi dogs used conventional PCR on brain and muscle tissue to amplify the Nc5 region [4]. In southeast Australia, moderate detection rates of N. caninum in wild dog populations were achieved through real time PCR of fecal samples [22].
Immunohistochemistry Workflow
The decision tree for diagnostic confirmation in suspected neosporosis involves an algorithm integrating serology, PCR, and IHC.
graph TD
A[Clinical Suspicion: Neuromuscular signs in dog OR Abortion in cattle], > B{Serology: Anti-N. caninum IgG/IgM}
B, >|Positive| C[PCR on EDTA blood, CSF or fetal brain]
B, >|Negative + high clinical suspicion| D[Advance to biopsy or necropsy]
C, >|Positive| E[Immunohistochemistry on tissue sections]
C, >|Negative| D
D, > E
E, >|Positve staining: tachyzoites/cysts| F[Confirm Neospora caninum diagnosis]
E, >|Negative| G[Consider alternate causes: Toxoplasma, Hammondia, immune-mediated disease]
The central role of IHC is to provide spatial and cellular context for parasite detection, confirming that PCR positive samples are associated with active tissue infection.
Clinical Management
Neosporosis in Dogs
There is no approved therapy that eliminates Neospora caninum infection. The goal of treatment is to arrest tachyzoite replication, reduce inflammation, and allow the host immune system to control the infection. The most widely used regimen is a combination of clindamycin (10 to 20 mg/kg orally every 12 hours) and trimethoprim-sulfonamide (15 to 30 mg/kg orally every 12 hours). Corticosteroids are contraindicated except for short term management of severe inflammatory central nervous system edema, as they can trigger reactivation of latent infection. Prognosis is guarded in dogs with severe ascending paralysis; mild to moderate cases may recover with early intervention. A multimodal diagnostic and therapeutic approach is necessary in cases of neuromuscular neosporosis [23].
Bovine Neosporosis
There is no effective treatment for Neospora caninum in cattle. Vaccines have been developed but their efficacy is inconsistent. Management relies on prevention: minimizing exposure of cattle to dog feces through exclusion of canids from feed stores and calving areas, not feeding raw bovine placental or fetal tissues to dogs, and serological testing to identify chronically infected dams for culling. Reproductive management to avoid breeding seropositive replacement heifers can reduce the rate of vertical transmission, which is the dominant route of infection in dairy herds.
Bovine Abortion: Clinical and Economic Impact
Neosporosis accounts for a substantial proportion of bovine abortions worldwide, especially in dairy herds. In intensive dairy production systems, the association between seropositivity and abortion risk is well established. In one investigation, analysis of risk factors in dual purpose systems in Colombia identified dog ownership, age of dam, and multiparity as significant predictors of seropositivity [10]. In Brazil, serosurveys in dairy cattle have consistently linked seropositive herds with higher rates of fetal loss. The condition is endemic in many countries, and control efforts are complicated by the lack of a commercially viable vaccine.
Future Directions: Diagnostics and Control
Recent research has focused on understanding the molecular mechanisms of invasion and egress. The role of cGMP dependent protein kinase in calcium fluxes during egress has been elucidated through quantitative phosphoproteomic analysis [24]. Host resistance mechanisms have been investigated in rats, mice, and bovine cells, with interferon signaling pathways (interferon alfa and beta receptor) shown to be critical for control of infection [25, 26]. Immunization using a NcMYR1 gene knockout strain conferred effective protection in mouse models, suggesting that attenuated live vaccines may be a future avenue for development [27].
For diagnostics, the refinement of point-of-care molecular assays and the integration of immunohistochemistry with digital pathology will likely improve detection rates, particularly in cases where serology is negative. The use of TaqMan quantitative PCR remains vital for both research and diagnostic confirmation [21].
References
[1] Nguyen NPN, Ha HT, Pham BX et al. Seroprevalence of Neospora caninum Infection in Shelter Dogs from Hanoi, Vietnam. Animals (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/42071971/
[2] Galvão CMMQ, Leite DPSBM, Oliveira PRF et al. First serological investigation of Toxoplasma gondii, Neospora caninum, Leishmania infantum and Leptospira spp. in dogs from a Fulni-ô Indigenous community in Pernambuco, Brazil: a One Health perspective. Braz J Biol. 2026. https://pubmed.ncbi.nlm.nih.gov/41849483/
[3] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41843222/
[4] Mohammed AA, Soor TAH. First molecular identification and phylogenetic analysis of Neospora caninum in dogs from Sulaymaniyah province, Iraq. J Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41953733/
[5] Mukbel RM, Okour AA, Abu-Halaweh MM et al. Molecular and serological prevalence rates of Neospora caninum infection in dogs from Jordan. Parasitol Res. 2024. https://pubmed.ncbi.nlm.nih.gov/39096359/
[6] Shahiduzzaman M, Biswas P, Kabir A et al. First report of Neospora caninum from aborted fetuses of cattle, sheep, and goats in Bangladesh. J Adv Vet Anim Res. 2024. https://pubmed.ncbi.nlm.nih.gov/39605763/
[7] Gos ML, Venturini MC, De Felice L et al. A 20-year serological survey of Toxoplasma gondii and Neospora caninum infection in dogs with neuromuscular disorders from urban areas in Argentina. Vet Parasitol. 2024. https://pubmed.ncbi.nlm.nih.gov/38908047/
[8] Erez MS, Kozan E, Arslan SM et al. Nationwide herd-level seroprevalence of Neospora caninum in dairy herds in Türkiye based on bulk tank milk ELISA and identification of associated risk factors. Front Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41800310/
[9] Godoy-Alfaro C, Muñoz-Zanzi C, Jara-Méndez S et al. Seropositivity and Risk Factors for Toxoplasma gondii and Neospora caninum in Intensive Dairy Cattle from Different Farms in Central Chile. Animals (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/42193747/
[10] Murcia-Mono CA, Falla-Tapias S, Cabrera-Ospina BK et al. Epidemiology of Bovine Neosporosis in Relation to Socioeconomic, Demographic, and Transmissibility Factors in Dual-Purpose Production Systems in Colombia. Epidemiologia (Basel). 2024. https://pubmed.ncbi.nlm.nih.gov/39727428/
[11] Çirak VY, Kisadere I, Cihan H et al. Seroprevalence of Neospora caninum infection in cattle and yaks in the northern mountainous regions of Kyrgyzstan. Vet Parasitol Reg Stud Reports. 2025. https://pubmed.ncbi.nlm.nih.gov/40518251/
[12] Ali AO, Qossa W, Khalifa FA et al. Seroprevalence and risk factors associated with Neospora caninum infection in water buffaloes (Bubalus bubalis) in Sohag, Egypt. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741035/
[13] Tsakmakidis I, Lefkaditis M, Sofia M et al. Prevalence of Neospora caninum and associated risk factors in semi-intensive female water buffaloes reared in Greece, using an ELISA kit on milk samples. Vet Parasitol Reg Stud Reports. 2024. https://pubmed.ncbi.nlm.nih.gov/39237227/
[14] Kennedy A, White JD, Child G. Neosporosis in 21 adult dogs, 2010-2023. J Vet Intern Med. 2024. https://pubmed.ncbi.nlm.nih.gov/39441649/
[15] English AL, Klutzke JB, Thomovsky SA et al. Disseminated Neospora caninum Encephalomyelitis and Myositis in a 3-Month-Old Cane Corso Puppy. Vet Sci. 2024. https://pubmed.ncbi.nlm.nih.gov/39591318/
[16] Henry P, Rees P, Morrison T et al. Successful Management of Presumed Reactivation of Neospora caninum Following Immunosuppression for Immune Thrombocytopenia in an Adult Doberman. Vet Med Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/40434946/
[17] Rodriguez CL, Fowler K, Lahmers K et al. Seronegative disseminated neosporosis with fatal outcome in an adult dog following prednisone therapy. J Vet Diagn Invest. 2026. https://pubmed.ncbi.nlm.nih.gov/41612780/
[18] Zilli J, Fleming K, Fisher C et al. Masticatory muscle changes on magnetic resonance imaging of dogs with Neospora caninum compared to meningoencephalitis of unknown origin. Front Vet Sci. 2024. https://pubmed.ncbi.nlm.nih.gov/39840346/
[19] Choi EA, Sinnott DM, Ahmed AA et al. Neutrophilic cholangitis associated with intracholangiocytic Hammondia protozoa confirmed in 2 dogs and suspected in 2 dogs. Vet Pathol. 2026. https://pubmed.ncbi.nlm.nih.gov/42109262/
[20] Giannino D, Peters-Kennedy J, Lejeune M et al. Pancreatic and biliary duct Hammondia heydorni infection in a dog fed a raw elk-meat diet. J Vet Diagn Invest. 2026. https://pubmed.ncbi.nlm.nih.gov/41685531/
[21] Rico-San Román L, Hänggeli KPA, Hemphill A et al. TaqMan-quantitative PCR assays applied in Neospora caninum knock-outs generated through CRISPR-Cas9 allow to determine the copy numbers of integrated dihydrofolate reductase-thymidylate synthase drug selectable markers. Front Cell Infect Microbiol. 2024. https://pubmed.ncbi.nlm.nih.gov/38975328/
[22] Stott EK, Huaman JL, Carvalho TG et al. Moderate Neospora caninum Detection in Wild Dog Populations in Southeast Australia. J Wildl Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/40288778/
[23] Alf V, Tirrito F, Fischer A et al. A multimodal approach to diagnosis of neuromuscular neosporosis in dogs. J Vet Intern Med. 2024. https://pubmed.ncbi.nlm.nih.gov/39016150/
[24] Wang X, Guo K, Shan Z et al. Unveiling the impact of cGMP-dependent protein kinase of Neospora caninum on calcium fluxes and egress functions through quantitative phosphoproteome analysis. Commun Biol. 2025. https://pubmed.ncbi.nlm.nih.gov/40360693/
[25] Miranda VDS, Ferreira FB, Silva MF et al. Interferon alfa and beta receptor confers resistance against Neospora caninum infection in mice. Vet Parasitol. 2025. https://pubmed.ncbi.nlm.nih.gov/40749331/
[26] Azam AR, Mia MM, Bedwani J et al. Upregulated small GTPase immunity-associated proteins confer resistance to Neospora caninum in rat and bovine cells. Front Cell Infect Microbiol. 2025. https://pubmed.ncbi.nlm.nih.gov/41163850/
[27] Du B, Chen M, Chang L et al. Immunization with the NcMYR1 gene knockout strain effectively protected C57BL/6 mice and their pups against the Neospora caninum challenge. Virulence. 2024. https://pubmed.ncbi.nlm.nih.gov/39607301/
[28] Nguyen NPN, Nguyen TT, Phanpha C et al. Occurrence of Toxoplasma gondii and Neospora caninum Antibodies in Pet Cats and Dogs in Pathum Thani, Thailand. Trop Med Infect Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42042950/
[29] Rivas López PC, Idarraga-Bedoya SE, Mendoza-Morales LF et al. Current knowledge about neosporosis in Colombia. Vet Res Commun. 2026. https://pubmed.ncbi.nlm.nih.gov/41642379/
[30] Erguney MC, Aydın N. Investigation of neosporosis in cattle in the Artvin region by ELISA method. Pol J Vet Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/41416600/
[31] Nägler IM, Fayyad A, Puff C et al. Retrospective Analysis of Central Nervous System Diseases in Dogs, with Special Focus on Non-Suppurative Encephalomyelitis (1962-2022). Vet Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/41012794/
[32] Hatam GR, Mikaeili F, Asgari Q et al. Molecular Detection of Neospora Caninum in Different Tissues of Dogs and Cats in Shiraz, Iran. Vet Med Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/40493562/
[33] Castaldo E, Basso W, Moré G et al. Nationwide serological survey and risk factors for Toxoplasma gondii and Neospora caninum infections in alpacas (Vicugna pacos) and llamas (Lama glama) in Italy. Res Vet Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/40460623/
[34] Al-Taee AHM, Ali MJ. Serological diagnosis of Neospora caninum in domestic and stray dogs in Babylon province, Iraq. Open Vet J. 2025. https://pubmed.ncbi.nlm.nih.gov/40453863/
[35] Rimayanti R, Khairullah AR, Utama S et al. Review of neosporosis: Disease insights and control approaches. Open Vet J. 2025. https://pubmed.ncbi.nlm.nih.gov/40276172/
[36] Minicucci LA, Carstensen M, Cornicelli L et al. Risk perception and transmission potential of Neospora caninum at the wildlife and livestock interface in Minnesota. Front Vet Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/40115835/
[37] Talib MT, Nasir A, Kashif M et al. Prevalence of anti-N. caninum and anti-N. hughesi antibodies in horses and associated risk factors in two selected equine zones of Punjab, Pakistan. Vet Parasitol Reg Stud Reports. 2025. https://pubmed.ncbi.nlm.nih.gov/40049998/
[38] Qian W, Chen Y, Li C et al. Neospora caninum Inhibits Lewis Cancer and B16f10 Melanoma Lung Metastasis Development by Activating the Immune Response in Murine Models. Acta Parasitol. 2025. https://pubmed.ncbi.nlm.nih.gov/39918646/
[39] Mishra V, Mitra P, Shinde S et al. Neospora caninum in pigs and pig farmers in India: Examining the prevalence, immunodominant antigens and associated risk factors. Microb Pathog. 2025. https://pubmed.ncbi.nlm.nih.gov/39894235/
[40] Jabar Aziz K, Mikaeel FB, Azeez SH et al. Seroepidemiological study of Neospora caninum in equids using c-ELISA in Erbil Province, Iraq. Folia Parasitol. 2024. https://pubmed.ncbi.nlm.nih.gov/39632700/
[41] Jiménez-Martín D, Huertas-López A, Cerón JJ et al. Epidemiological surveillance of Neospora caninum in sheep (Ovis aries) and European mouflon (Ovis aries musimon) in southern Spain. Res Vet Sci. 2024. https://pubmed.ncbi.nlm.nih.gov/39500245/
[42] Gutiérrez LT, Alva G, Godoy DJ et al. Impact of production practices and sanitary management on the prevalence of Neospora caninum and bluetongue virus in Creole goats from the tropical dry forest of Utcubamba, Peru. Am J Vet Res. 2025. https://pubmed.ncbi.nlm.nih.gov/39496216/
[43] Morganti G, Rigamonti G, Brustenga L et al. Exploring similarities and differences between Toxoplasma gondii and Neospora caninum infections in dogs. Vet Res Commun. 2024. https://pubmed.ncbi.nlm.nih.gov/39320405/
[44] Shams F, Jokar M, Abdous A et al. Seroprevalence of Toxoplasma gondii and Neospora spp. in horse population of Tehran, Iran. Sci Rep. 2024. https://pubmed.ncbi.nlm.nih.gov/39048639/
[45] Remor-Sebolt AP, de Lima FR, Américo L et al. Occurrence of antibodies and epidemiological significance of Toxoplasma Gondii and Neospora caninum infections in canine populations of Laguna, State of Santa Catarina. Vet Res Commun. 2024. https://pubmed.ncbi.nlm.nih.gov/38976166/
[46] Perin PP, Arias-Pacheco CA, Andrade LO et al. Toxoplasma gondii and Neospora caninum in invasive wild boars (Sus scrofa) and hunting dogs from Brazil. Int J Parasitol Parasites Wildl. 2024. https://pubmed.ncbi.nlm.nih.gov/38966859/